This interesting work by Craig Paardekooper is sufficient grounds for a formal investigation. We need much more transparency by the manufacturers regarding lot sizes and distribution patterns. Furthermore, I just downloaded the expiration data and found that 19.5% of the 354550 rows in the US VAERS data that have expiration data have RECVDATE > Expiration Date. This appears to be grounds for lawsuits for administration of expired product: approximately 1 in 5 vials being injected and reported in VAERS are expired.
This interesting work by Craig Paardekooper is sufficient grounds for a formal investigation. We need much more transparency by the manufacturers regarding lot sizes and distribution patterns. Furthermore, I just downloaded the expiration data and found that 19.5% of the 354550 rows in the US VAERS data that have expiration data have RECVDATE > Expiration Date. This appears to be grounds for lawsuits for administration of expired product: approximately 1 in 5 vials being injected and reported in VAERS are expired.